- Home
- MNPR vs HITI Comparison
MNPR vs HITI Comparison
Compare MNPR & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- HITI
- Stock Information
- Founded
- MNPR 2014
- HITI 2009
- Country
- MNPR United States
- HITI Canada
- Employees
- MNPR N/A
- HITI N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- HITI
- Sector
- MNPR Health Care
- HITI
- Exchange
- MNPR Nasdaq
- HITI Nasdaq
- Market Cap
- MNPR 250.0M
- HITI 217.9M
- IPO Year
- MNPR 2019
- HITI N/A
- Fundamental
- Price
- MNPR $40.25
- HITI $2.59
- Analyst Decision
- MNPR Strong Buy
- HITI Strong Buy
- Analyst Count
- MNPR 4
- HITI 1
- Target Price
- MNPR $43.00
- HITI $4.50
- AVG Volume (30 Days)
- MNPR 71.2K
- HITI 691.6K
- Earning Date
- MNPR 03-27-2025
- HITI 03-14-2025
- Dividend Yield
- MNPR N/A
- HITI N/A
- EPS Growth
- MNPR N/A
- HITI N/A
- EPS
- MNPR N/A
- HITI N/A
- Revenue
- MNPR N/A
- HITI $374,815,931.00
- Revenue This Year
- MNPR N/A
- HITI $14.48
- Revenue Next Year
- MNPR N/A
- HITI $16.50
- P/E Ratio
- MNPR N/A
- HITI N/A
- Revenue Growth
- MNPR N/A
- HITI 7.10
- 52 Week Low
- MNPR $1.72
- HITI $1.57
- 52 Week High
- MNPR $54.30
- HITI $3.62
- Technical
- Relative Strength Index (RSI)
- MNPR 49.34
- HITI 38.71
- Support Level
- MNPR $38.80
- HITI $2.54
- Resistance Level
- MNPR $45.60
- HITI $2.64
- Average True Range (ATR)
- MNPR 5.19
- HITI 0.12
- MACD
- MNPR -1.50
- HITI -0.01
- Stochastic Oscillator
- MNPR 9.37
- HITI 11.36
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.